THE DEAL, AT A GLANCE
From the announcementCity Therapeutics
01What it doesThe business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedCity Therapeutics raised $99.5M Series B, announced 2026-06-08From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersCity Therapeutics' $99.5M Series B is a mid-to-upper Healthcare & Life Sciences financing signal, positioned above the median but below the largest tracked rounds in an…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
City Therapeutics · Financing Record
Explore source-linked visual explanations for City Therapeutics. Unsupported claims are withheld while source review continues.
Record 5730 · Recorded date: 2026-06-08
Explore company records →